Pulmonary embolism: Difference between revisions
Kashish Goel (talk | contribs) |
No edit summary |
||
| Line 51: | Line 51: | ||
:*[[Pulmonary thrombectomy|Catheter-Based Interventions]] | [[Pulmonary thrombectomy#Surgical thrombectomy|Surgical Embolectomy]] | [[Inferior vena cava filter|Inferior Vena Cava Filters]] | [[Thromboreductive Strategies]] | [[Pulmonary embolism angioplasty|Percutaneous Transluminal Venous Angioplasty and Stent Placement]] | [[Pulmonary thromboendarterectomy|Pulmonary Endarterectomy]] | :*[[Pulmonary thrombectomy|Catheter-Based Interventions]] | [[Pulmonary thrombectomy#Surgical thrombectomy|Surgical Embolectomy]] | [[Inferior vena cava filter|Inferior Vena Cava Filters]] | [[Thromboreductive Strategies]] | [[Pulmonary embolism angioplasty|Percutaneous Transluminal Venous Angioplasty and Stent Placement]] | [[Pulmonary thromboendarterectomy|Pulmonary Endarterectomy]] | ||
==Discharge Care== | |||
[[Pulmonary embolism patient discharge care|Discharge Care]] | [[Pulmonary embolism follow-up/recurrence|Follow-Up/Recurrence]] | [[Pulmonary embolism support group|Support group]] | |||
==[[Pulmonary embolism landmark trials|Landmark Trials]]== | |||
==[[Pulmonary embolism future perspective|Future Perspective]]== | |||
==Special Scenarios== | |||
[[Pulmonary embolism special scenario#Pregnancy]] | |||
[[Pulmonary embolism special scenario#Cancer]] | |||
==Guidelines== | ==Guidelines== | ||
| Line 65: | Line 75: | ||
*'''Treatment:''' [[ESC guidelines for treatment of pulmonary embolism#ESC Guidelines treatment High-risk pulmonary embolism (DO NOT EDIT)|High-risk pulmonary embolism]] | [[ESC guidelines for treatment of pulmonary embolism#ESC Guidelines treatment Non-high-risk pulmonary embolism (DO NOT EDIT)|Non-high-risk pulmonary embolism]] | [[ESC guidelines for treatment of pulmonary embolism#ESC Guidelines Recommendations Long-term treatment (DO NOT EDIT)|Long-term treatment]] | [[Pulmonary embolism guidelines inferior vena cava filter#ESC Guidelines - Recommendations for Use of IVC Filters (DO NOT EDIT)|Inferior vena cava filters]] | [[Pulmonary embolism treatment thrombolysis#ACC/AHA Guidelines- Recommendations for Fibrinolysis for Acute PE (DO NOT EDIT)|Thrombolysis]] | *'''Treatment:''' [[ESC guidelines for treatment of pulmonary embolism#ESC Guidelines treatment High-risk pulmonary embolism (DO NOT EDIT)|High-risk pulmonary embolism]] | [[ESC guidelines for treatment of pulmonary embolism#ESC Guidelines treatment Non-high-risk pulmonary embolism (DO NOT EDIT)|Non-high-risk pulmonary embolism]] | [[ESC guidelines for treatment of pulmonary embolism#ESC Guidelines Recommendations Long-term treatment (DO NOT EDIT)|Long-term treatment]] | [[Pulmonary embolism guidelines inferior vena cava filter#ESC Guidelines - Recommendations for Use of IVC Filters (DO NOT EDIT)|Inferior vena cava filters]] | [[Pulmonary embolism treatment thrombolysis#ACC/AHA Guidelines- Recommendations for Fibrinolysis for Acute PE (DO NOT EDIT)|Thrombolysis]] | ||
==[[Pulmonary embolism case studies|Case studies]]== | ==[[Pulmonary embolism case studies|Case studies]]== | ||
Revision as of 00:17, 7 October 2012
For patient information click here
| Pulmonary embolism | |
| ICD-10 | I26 |
|---|---|
| ICD-9 | 415.1 |
| DiseasesDB | 10956 |
| MedlinePlus | 000132 |
|
Pulmonary Embolism Microchapters |
|
Diagnosis |
|---|
|
Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores |
|
Treatment |
|
Follow-Up |
|
Special Scenario |
|
Trials |
|
Case Studies |
|
Pulmonary embolism On the Web |
Editor(s)-In-Chief: The APEX Trial Investigators, C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Historical Perspective
Classification Scheme
I: Acute pulmonary embolism | Chronic pulmonary embolism
II: Massive pulmonary embolism | Submassive pulmonary embolism | Low-risk pulmonary embolism
Pathophysiology
Epidemiology and Demographics
Risk factors
Natural History, Complications & Prognosis
Differential Diagnosis
Pretest probability of PE
Wells Score | Original Geneva Score | Revised Geneva Score | Simplified Geneva Score | PE Rule-out Criteria | Summary of PE Clinical Probability based on Clinical Prediction Rules | ESC Guideline Recommendations
Diagnosis
History & Symptoms | Physical Examination | Laboratory Tests | Arterial Blood Gas | D-dimer | Biomarkers | Electrocardiogram | Chest x ray | Ventilation/Perfusion scan | Echocardiography | Compression Ultrasonography | Chest CT | CT Pulmonary Angiography (CTPA) | MRI
Treatment
Treatment Approach
Medical Therapy:
- Fibrinolytic: Thrombolysis
Surgery:
Discharge Care
Discharge Care | Follow-Up/Recurrence | Support group
Landmark Trials
Future Perspective
Special Scenarios
Pulmonary embolism special scenario#Pregnancy Pulmonary embolism special scenario#Cancer
Guidelines
ACCP Guidelines
Initial treatment of Acute PE | Guidelines for Long-term treatment of PE | Chronic Thromboembolic Pulmonary Hypertension
ACC/AHA Guidelines
Guidelines for Initial Anticoagulation for Acute PE | Surgical embolectomy | Inferior vena cava filters | Iliofemoral DVT management guidelines | Compression therapy for DVT | Thromboreductive Strategies | Percutaneous Transluminal Venous Angioplasty and Stent Placement
ESC Guidelines
- Diagnosis: Suspected high-risk PE | Suspected non-high-risk PE | Low clinical probability | Intermediate clinical probability | High clinical probability
- Treatment: High-risk pulmonary embolism | Non-high-risk pulmonary embolism | Long-term treatment | Inferior vena cava filters | Thrombolysis